Eupraxia Pharmaceuticals Q4 EPS $(0.37) Misses $(0.16) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings MissesNews
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.16) by 131.25 percent. This is a 68.18 percent decrease over losses of $(0.22) per
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.16) by 131.25 percent. This is a 68.18 percent decrease over losses of $(0.22) per share from the same period last year.